1. 1. Etminan M, Samii A. Pharmacoepidemiology I: A Review of Pharmacoepidemiologic Study Designs. Pharmacother 2004; 24: 964-969. Ref.: https://goo.gl/rydTzd
2. 2. WHO. Programme for International Drug Monitoring. http://www.who.int/medicines/areas/quality_safety/safety_efficacy/National_PV_Centres_Map/en/. 2014.[Acessed in March 2015].
3. 3. Papich MG, Riviere JE, Ames A. Chloramphenicol andderiva-tives, macrolides, lincosamides, and miscellaneous antimicro-bials," In in Veterinary Pharmacology and Therapeutics,, Adams, H.R.E., ,, ed. (Iowa, USA,, Iowa State University Press,), 2001. 868-897.
4. 4. Susan LHG, Tucker DT, Robin SR. A study of tilmicosin residues in milk following subcutaneous administration to lactating dairy cows. Can Vet J. 1993; 34: 619-621. Ref.: https://goo.gl/9iiMe6
5. 5. Gheith I, El-Mahmoudy A, Elmajdoub A, Awidat A. Pharmacovigilance of Tilmicosin in Mice. Act Scient Vet. 2015; 43: 1318. Ref.: https://goo.gl/eNSjT2